about
Finding time to make the right decision: using frozen section to inform intra-operative management of suspicious ovarian massesLymphadenectomy for the management of endometrial cancerPoly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancerPegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancerImproving Outcomes in Gynaecological Cancer: The Benefits of SubspecialisationPegylated liposomal doxorubicin for relapsed epithelial ovarian cancerChemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancerPegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancerAngiogenesis inhibitors for the treatment of ovarian cancerEpidermal growth factor receptor blockers for the treatment of ovarian cancerChemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancerWorking together to shape the endometrial cancer research agenda: The top ten unanswered research questions.Lymphadenectomy for the management of endometrial cancer.Lymphadenectomy for Treatment of Early-Stage Endometrial Cancer.Borderline ovarian tumours: balancing risks of recurrence over decades.British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practiceBritish Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU)Patient-initiated follow-up after treatment for low risk endometrial cancer: a prospective audit of outcomes and cost benefits
P50
Q24185988-FFFB2368-FFB1-4321-8087-2BF543C3AAA0Q24187095-B23FAEB8-090F-49B5-AB24-7AC9CB46824BQ24187899-07FDAB45-2151-47C1-A17A-B4CEF37CFE06Q24198096-5ECEBC86-6F43-408C-B600-4139B8B71DC2Q24200973-5A4FFAA1-BEA8-4DEF-A7BF-9F33B05F9FFBQ24201282-6EA5EA02-FB95-43C3-9375-19A07387F1AAQ24201686-48750FFE-BFC8-41A4-BB68-BC750211C528Q24202975-720C1D7A-6648-4EBD-92D9-E3761E88DD62Q24234292-125B71A4-6786-4763-BD15-14C0CA9A0EB1Q24236143-FF1FE8EA-3BF7-467E-9C49-B8A1847456C8Q24242912-61EB254D-F47A-4928-AB9A-175C10B2C36BQ36122806-596E4559-AD20-43E3-B469-BAF7BAFB61EAQ47884971-2EF27326-6CAD-45A5-93E7-FBA81E19686BQ52953505-9804830F-44E5-4DE9-AE51-DE9E32AA9BC3Q53122026-1C414D5C-1C45-46E9-A021-01203B3DD092Q87958838-1300F95F-A032-4757-834E-F3A89DB87CEBQ92090728-0E6B8E10-2473-45AA-A025-2B12B34C2E8AQ94590508-2920A1F4-F063-4658-BA84-3E4599A482CA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jo Morrison
@ast
Jo Morrison
@en
Jo Morrison
@es
Jo Morrison
@fr
Jo Morrison
@nl
Jo Morrison
@sl
جو موريسون
@ar
type
label
Jo Morrison
@ast
Jo Morrison
@en
Jo Morrison
@es
Jo Morrison
@fr
Jo Morrison
@nl
Jo Morrison
@sl
جو موريسون
@ar
prefLabel
Jo Morrison
@ast
Jo Morrison
@en
Jo Morrison
@es
Jo Morrison
@fr
Jo Morrison
@nl
Jo Morrison
@sl
جو موريسون
@ar
P106
P31
P496
0000-0003-0000-520X